Katherine Stuart

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+)

Vincent Leroy, Peter Angus, Jean–Pierre Bronowicki et al. · Hepatology · 2016 · 278 citations · Full text

The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients

Katherine Stuart, Frances Busfield, Elizabeth C. Jazwinska et al. · Journal of Hepatology · 1998 · 128 citations

C282y Mutation, Genetics, Pathogenesis +7

Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis

Andrew J. Muir, Fred Poordad, Jacob Lalezari et al. · JAMA · 2015 · 126 citations · Full text

The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial

Leon A. Adams, Dorothy H. Crawford, Katherine Stuart et al. · Hepatology · 2014 · 111 citations

Underappreciation of non‐alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis

Preya Patel, Xuan Banh, Leigh U. Horsfall et al. · Internal Medicine Journal · 2017 · 111 citations